These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30666403)

  • 1. Characterization of blood-brain barrier integrity in a B-cell-dependent mouse model of multiple sclerosis.
    Bell L; Koeniger T; Tacke S; Kuerten S
    Histochem Cell Biol; 2019 Jun; 151(6):489-499. PubMed ID: 30666403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of LTi and T
    Schropp V; Rohde J; Rovituso DM; Jabari S; Bharti R; Kuerten S
    J Neuroinflammation; 2019 May; 16(1):111. PubMed ID: 31138214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
    Simon M; Ipek R; Homola GA; Rovituso DM; Schampel A; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2018 Aug; 15(1):225. PubMed ID: 30098594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
    Bail K; Notz Q; Rovituso DM; Schampel A; Wunsch M; Koeniger T; Schropp V; Bharti R; Scholz CJ; Foerstner KU; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2017 Jul; 14(1):148. PubMed ID: 28738885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
    Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
    Tietz SM; Engelhardt B
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
    Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
    Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
    Batoulis H; Wunsch M; Birkenheier J; Rottlaender A; Gorboulev V; Kuerten S
    Clin Immunol; 2015 May; 158(1):47-58. PubMed ID: 25796192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
    Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-immortalized B lymphocytes exacerbate experimental autoimmune encephalomyelitis in xenograft mice.
    Polepole P; Bartenslager A; Liu Y; Petro TM; Fernando S; Zhang L
    J Med Virol; 2021 Jun; 93(6):3813-3823. PubMed ID: 32543727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-26, preferentially produced by T
    Broux B; Zandee S; Gowing E; Charabati M; Lécuyer MA; Tastet O; Hachehouche L; Bourbonnière L; Ouimet JP; Lemaitre F; Larouche S; Cayrol R; Bouthillier A; Moumdjian R; Lahav B; Poirier J; Duquette P; Arbour N; Peelen E; Prat A
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32788322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a CD19 PET tracer for detecting B cells in a mouse model of multiple sclerosis.
    Stevens MY; Cropper HC; Lucot KL; Chaney AM; Lechtenberg KJ; Jackson IM; Buckwalter MS; James ML
    J Neuroinflammation; 2020 Sep; 17(1):275. PubMed ID: 32948198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis.
    Kuerten S; Angelov DN
    Ann Anat; 2008; 190(1):1-15. PubMed ID: 18342137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
    Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
    Front Immunol; 2022; 13():861486. PubMed ID: 35664003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.